| Dr Thomas Dix Henry, MD | |
|
9101 Stony Point Dr, Richmond, VA 23235 | |
| (804) 330-9105 | |
| (804) 287-6119 |
| Full Name | Dr Thomas Dix Henry |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 23 Years |
| Location | 9101 Stony Point Dr, Richmond, Virginia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104848902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 0101239794 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Urology Center | 2365339264 | 82 |
News Archive
The American Association of Anatomist's (AAA) Young Investigator Awards combine three long-standing AAA awards-Bensley, Herrick, and Mossman-with the recently established Morphological Sciences Award, all recognizing investigators in the early stages of their careers who have made important contributions to biomedical science through their research in cell/molecular biology, developmental biology, comparative neuroanatomy, or the morphological sciences.
A University of Texas at Arlington researcher has been awarded a National Science Foundation grant to help develop a network that will lead to improvements for people with disabilities who depend on wheelchair mounted robotic arms.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog "is the fourth of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized recently by MLI, a program of Aspen Global Health and Development."
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
› Verified 2 days ago
| Entity Name | Virginia Urology Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164485876 PECOS PAC ID: 2365339264 Enrollment ID: O20040304000209 |
News Archive
The American Association of Anatomist's (AAA) Young Investigator Awards combine three long-standing AAA awards-Bensley, Herrick, and Mossman-with the recently established Morphological Sciences Award, all recognizing investigators in the early stages of their careers who have made important contributions to biomedical science through their research in cell/molecular biology, developmental biology, comparative neuroanatomy, or the morphological sciences.
A University of Texas at Arlington researcher has been awarded a National Science Foundation grant to help develop a network that will lead to improvements for people with disabilities who depend on wheelchair mounted robotic arms.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog "is the fourth of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized recently by MLI, a program of Aspen Global Health and Development."
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
› Verified 2 days ago
| Entity Name | Fred Smeltzer Md & Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639122286 PECOS PAC ID: 8921078304 Enrollment ID: O20130129000671 |
News Archive
The American Association of Anatomist's (AAA) Young Investigator Awards combine three long-standing AAA awards-Bensley, Herrick, and Mossman-with the recently established Morphological Sciences Award, all recognizing investigators in the early stages of their careers who have made important contributions to biomedical science through their research in cell/molecular biology, developmental biology, comparative neuroanatomy, or the morphological sciences.
A University of Texas at Arlington researcher has been awarded a National Science Foundation grant to help develop a network that will lead to improvements for people with disabilities who depend on wheelchair mounted robotic arms.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog "is the fourth of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized recently by MLI, a program of Aspen Global Health and Development."
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
› Verified 2 days ago
| Entity Name | Angelina Diagnostic Radiology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033175302 PECOS PAC ID: 1850380890 Enrollment ID: O20220613000074 |
News Archive
The American Association of Anatomist's (AAA) Young Investigator Awards combine three long-standing AAA awards-Bensley, Herrick, and Mossman-with the recently established Morphological Sciences Award, all recognizing investigators in the early stages of their careers who have made important contributions to biomedical science through their research in cell/molecular biology, developmental biology, comparative neuroanatomy, or the morphological sciences.
A University of Texas at Arlington researcher has been awarded a National Science Foundation grant to help develop a network that will lead to improvements for people with disabilities who depend on wheelchair mounted robotic arms.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog "is the fourth of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized recently by MLI, a program of Aspen Global Health and Development."
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Dix Henry, MD 9101 Stony Point Dr, Richmond, VA 23235 Ph: (804) 330-9105 | Dr Thomas Dix Henry, MD 9101 Stony Point Dr, Richmond, VA 23235 Ph: (804) 330-9105 |
News Archive
The American Association of Anatomist's (AAA) Young Investigator Awards combine three long-standing AAA awards-Bensley, Herrick, and Mossman-with the recently established Morphological Sciences Award, all recognizing investigators in the early stages of their careers who have made important contributions to biomedical science through their research in cell/molecular biology, developmental biology, comparative neuroanatomy, or the morphological sciences.
A University of Texas at Arlington researcher has been awarded a National Science Foundation grant to help develop a network that will lead to improvements for people with disabilities who depend on wheelchair mounted robotic arms.
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog "is the fourth of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized recently by MLI, a program of Aspen Global Health and Development."
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
› Verified 2 days ago
Dr. Christine H Llewellyn, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall Street, Radiology, Richmond, VA 23298 Phone: 804-828-8262 Fax: 804-828-6129 | |
Kathryn S. Jones, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1250 E Marshall St, Richmond, VA 23298 Phone: 804-628-3580 Fax: 804-628-3593 | |
Dr. Richard Westwood Fuller, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2602 Buford Rd, Richmond, VA 23235 Phone: 804-272-8806 | |
Michelle S. Kraut, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 7110 Forest Ave, Suite 100, Richmond, VA 23226 Phone: 804-673-4200 Fax: 804-673-6513 | |
Dr. Matthew L Cohen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2602 Buford Rd, Richmond, VA 23235 Phone: 804-272-8806 | |
Dr. Roger Headly Tutton, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1839 Monument Ave, Richmond, VA 23220 Phone: 804-355-7788 | |
Ryan D Clayton, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1250 E Marshall St, Radiology, Richmond, VA 23298 Phone: 804-628-6831 Fax: 804-628-1132 |